Rutin effectively ameliorates the expression of biomarkers of the NF-κB inflammatory pathway, including NF-κB, IκB kinase (IKK)-α, and IKK-β in HT-29 colon cancer cells [119]. The gene discussed is NFKB1; the disease is malignant colon neoplasm.